Nikolaos Androulakis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bozionelou Vasiliki; Kalbakis Kostas; Vamvakas Lambros; Agelaki Sofia; Androulakis Nikolaos; Kalykaki Antonia; Georgoulias Vassilis; Mavroudis Dimitris
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Georgoulias Vassilis; Androulakis Nikolaos; Kotsakis Athanasios; Hatzidaki Dora; Syrigos Kostas; Polyzos Aris; Agelidou Athina; Varthalitis Ioannis; Ziras Nikoalos; Agelidou Maria; Chandrinos Vassilis; Boukovinas Ioannis; Geroyianni Alexandra; Vamvakas Lambros; Mavroudis Dimitris
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Bozionelou V; Vamvakas L; Pappas P; Agelaki S; Androulakis N; Kalykaki A; Nikolaidou M; Kentepozidis N; Giassas S; Marselos M; Georgoulias V; Mavroudis D
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nikolaos Androulakis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bozionelou Vasiliki; Kalbakis Kostas; Vamvakas Lambros; Agelaki Sofia; Androulakis Nikolaos; Kalykaki Antonia; Georgoulias Vassilis; Mavroudis Dimitris
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 2009;64(4):785-91.
2008: Georgoulias Vassilis; Androulakis Nikolaos; Kotsakis Athanasios; Hatzidaki Dora; Syrigos Kostas; Polyzos Aris; Agelidou Athina; Varthalitis Ioannis; Ziras Nikoalos; Agelidou Maria; Chandrinos Vassilis; Boukovinas Ioannis; Geroyianni Alexandra; Vamvakas Lambros; Mavroudis Dimitris
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Lung cancer (Amsterdam, Netherlands) 2008;59(1):57-63.
2007: Bozionelou V; Vamvakas L; Pappas P; Agelaki S; Androulakis N; Kalykaki A; Nikolaidou M; Kentepozidis N; Giassas S; Marselos M; Georgoulias V; Mavroudis D
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.
British journal of cancer 2007;97(1):43-9.
2007: Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis A P; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):305-10.
2007: Emmanouilides Christos; Sfakiotaki Georgia; Androulakis Nikolaos; Kalbakis Kostas; Christophylakis Charalambos; Kalykaki Antonia; Vamvakas Lambros; Kotsakis Athanasios; Agelaki Sofia; Diamandidou Eleni; Touroutoglou Nikolaos; Chatzidakis Adam; Georgoulias Vassilis; Mavroudis Dimitris; Souglakos John
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
BMC cancer 2007;7():91.
2007: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Digestive diseases (Basel, Switzerland) 2007;25(1):100-5.
2006: Boukovinas I; Androulakis N; Vamvakas L; Papakotoulas P; Ziras N; Polyzos A; Kalykaki A; Kotsakis A; Xenidis N; Gioulmbasanis I; Mavroudis D; Georgoulias V
Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1687-92.
2006: Stathopoulos G P; Syrigos K; Aravantinos G; Polyzos A; Papakotoulas P; Fountzilas G; Potamianou A; Ziras N; Boukovinas J; Varthalitis J; Androulakis N; Kotsakis A; Samonis G; Georgoulias V
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
British journal of cancer 2006;95(5):587-92.
2006: Xenidis Nikos; Perraki Maria; Kafousi Maria; Apostolaki Stella; Bolonaki Irene; Stathopoulou Aliki; Kalbakis Kostas; Androulakis Nikos; Kouroussis Charalambos; Pallis Thanos; Christophylakis Charalambos; Argyraki Katerina; Lianidou Evi S; Stathopoulos Stathis; Georgoulias Vassilis; Mavroudis Dimitris
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3756-62.
2006: Makrantonakis P; Ziotopoulos P; Agelidou A; Polyzos A; Ziras A; Chandrinos V; Vossos A; Kalykaki A; Androulakis N; Geroyianni A; Georgoulias V;
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):85-90.
2006: Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):59-65.
2006: Pallis Athanasios G; Agelidou Athina; Papakotoulas Pavlos; Tsaroucha Aimilia; Agelidou Maria; Agelaki Sohia; Androulakis Nikolaos; Vamvakas Lambros; Gerogianni Athina; Kotsakis Athanasios; Kentepozidis Nikolaos; Georgoulias Vassilis
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):165-71.
2006: Souglakos J; Androulakis N; Syrigos K; Polyzos A; Ziras N; Athanasiadis A; Kakolyris S; Tsousis S; Kouroussis Ch; Vamvakas L; Kalykaki A; Samonis G; Mavroudis D; Georgoulias V
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
British journal of cancer 2006;94(6):798-805.
2006: Kotsakis A; Kouroussis Ch; Androulakis N; Agelaki S; Kalbakis K; Vamvakas L; Vardakis N; Kalykaki A; Polyzos A; Georgoulias V; Mavroudis D
A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.
Oncology 2006;71(3-4):190-6.
2006: Androulakis Nikolaos; Aravantinos Gerasimos; Syrigos Kostas; Polyzos Aris; Ziras Nikolaos; Tselepatiotis Evangelos; Samonis George; Kentepozidis Nikolaos; Giassas Stylianos; Vamvakas Lambros; Georgoulias Vassilis
Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.
Oncology 2006;70(4):280-4.
2006: Souglakos John; Vamvakas Lambros; Apostolaki Stella; Perraki Maria; Saridaki Zacharenia; Kazakou Irine; Pallis Athanasios; Kouroussis Charalambos; Androulakis Nikos; Kalbakis Kostas; Millaki Georgia; Mavroudis Dimitris; Georgoulias Vassilis
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status.
Breast cancer research : BCR 2006;8(4):R36.
2005: Georgoulias V; Agelidou A; Syrigos K; Rapti A; Agelidou M; Nikolakopoulos J; Polyzos A; Athanasiadis A; Tselepatiotis E; Androulakis N; Kalbakis K; Samonis G; Mavroudis D
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.
British journal of cancer 2005;93(7):763-9.
2005: Ziotopoulos Panagiotis; Androulakis Nikolaos; Mylonaki Efthimia; Chandrinos Vassilios; Zachariadis Emmanouel; Boukovinas Ioannis; Agelidou Athina; Kentepozidis Nikolaos; Ignatiadis Michail; Vossos Andreas; Georgoulias Vassilis;
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):115-22.
2005: Georgoulias Vassilis; Ardavanis Alexandros; Tsiafaki Xanthi; Agelidou Athina; Mixalopoulou Penelope; Anagnostopoulou Ourania; Ziotopoulos Panagiotis; Toubis Michael; Syrigos Kostas; Samaras Nikolaos; Polyzos Aris; Christou Anna; Kakolyris Stylianos; Kouroussis Charalambos; Androulakis Nikolaos; Samonis George; Chatzidaki Dora
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2937-45.
2005: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kouroussis Ch; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):47-52.
2005: Souglakos J; Pallis A; Kakolyris S; Mavroudis D; Androulakis N; Kouroussis C; Agelaki S; Xenidis N; Milaki G; Georgoulias V
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
Oncology 2005;69(5):384-90.
2005: Potamianou Anna; Androulakis Nikolaos; Papakotoulas Pavlos; Toufexi Helen; Latoufis Christos; Kouroussis Charalambos; Christofilakis Charalambos; Xenidis Nikolaos; Georgoulias Vassilios; Polyzos Aristidis
Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
Oncology 2005;69(4):348-53.
2005: Souglakos John; Kakolyris Stylianos; Vardakis Nikolaos; Androulakis Nikolaos; Mavroudis Dimitrios; Vamvakas Lambos; Kouroussis Charalambos; Agelaki Sophia; Saridaki Zacharenia; Georgoulias Vassilis
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
Cancer investigation 2005;23(6):505-10.
2005: Kouroussis Ch; Androulakis N; Vamvakas L; Kalykaki A; Spiridonakou S; Kentepozidis N; Saridaki Z; Xiropoulou El; Georgoulias V
Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors.
Oncology 2005;69(3):202-7.
2005: Androulakis Nikolaos; Syrigos Konstantinos; Polyzos Aristidis; Aravantinos Gerasimos; Stathopoulos George P; Ziras Nikolaos; Mallas Konstantinos; Vamvakas Lambros; Georgoulis Vassilis;
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study.
Cancer investigation 2005;23(1):9-12.
2004: Kouroussis Charalambos; Kalbakis Konstantinos; Androulakis Nikolaos; Agelaki Sophia; Vamvakas Lambros; Malas Konstantinos; Souglakos John; Vardakis Nikolaos; Georgoulias Vassilis
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Anticancer research 2004;24(6):4217-21.
2004: Souglakos J; Syrigos K; Potamianou A; Polyzos A; Boukovinas I; Androulakis N; Kouroussis Ch; Vardakis N; Christophilakis Ch; Kotsakis A; Georgoulias V
Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1204-9.
2004: Stathopoulos G P; Syrigos K; Polyzos A; Fountzilas G; Rigatos S K; Ziras N; Potamiannou A; Tsiakopoulos I; Androulakis N; Aravantinos G; Athanasiadis A; Papakotoulas P; Georgoulias V
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):224-9.
2004: Mavroudis D; Malamos N; Polyzos A; Kouroussis Ch; Christophilakis Ch; Varthalitis I; Androulakis N; Kalbakis K; Milaki G; Georgoulias V;
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2004;67(3-4):250-6.
2004: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Samonis G; Vardakis N; Amarantidis K; Agelaki S; Mavroudis D; Xenidis N; Georgoulias V
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
Oncology 2004;66(4):253-9.
2003: Souglakos John; Androulakis Nikolaos; Mavroudis Dimitrios; Kourousis Charalabos; Kakolyris Stylianos; Vardakis Nikolaos; Kalbakis Konstantinos; Pallis Athanasios; Ardavanis Alexandros; Varveris Charalabos; Georgoulias Vassilios
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1284-7.
2003: Pallis A G; Mavroudis D; Androulakis N; Souglakos J; Kouroussis C; Bozionelou V; Vlachonikolis I G; Georgoulias V
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.
Lung cancer (Amsterdam, Netherlands) 2003;40(3):301-7.
2003: Stathopoulos G P; Rigatos S K; Dimopoulos M A; Giannakakis T; Foutzilas G; Kouroussis C; Janninis D; Aravantinos G; Androulakis N; Agelaki S; Stathopoulos J G; Georgoulias V;
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):388-94.
2003: Mavroudis D; Pappas P; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Nikolaidou M; Samonis G; Marselos M; Georgoulias V
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):304-12.
2003: Kouroussis Charalambos; Agelaki Sophia; Mavroudis Dimitris; Kakolyris Stylianos; Androulakis Nick; Kalbakis Kostas; Souglakos John; Mallas Kostas; Bozionelou Vassiliki; Pallis Athanasios; Adamtziki Helen; Georgoulias Vassilis
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Anticancer research 2003;23(1B):785-91.
2003: Mavroudis D; Pavlakou G; Blazoyiannakis G; Veslemes M; Apostolopoulou F; Kouroussis Ch; Kakolyris S; Agelaki S; Androulakis N; Vardakis N; Magkanas E; Samonis G; Georgoulias V
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):71-6.
2003: Mavroudis D; Alexopoulos A; Malamos N; Ardavanis A; Kandylis C; Stavrinidis E; Kouroussis Ch; Agelaki S; Androulakis N; Bozionelou V; Georgoulias V
Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.
Oncology 2003;64(3):207-12.
2002: Androulakis N; Kouroussis C; Mavroudis D; Kakolyris S; Souglakos J; Agelaki S; Kalbakis K; Malas K; Pallis A; Samonis G; Georgoulias V
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(15):1992-7.
2002: Souglakos J; Mavroudis D; Kakolyris S; Kourousis Ch; Vardakis N; Androulakis N; Agelaki S; Kalbakis K; Tsetis D; Athanasiadis N; Samonis G; Georgoulias V
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2651-7.
2002: Vamvakas L; Kakolyris S; Kouroussis C; Kandilis K; Mavroudis D; Ziras N; Androulakis N; Kalbakis K; Sarra E; Souglakos J; Georgoulias V;
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study.
American journal of clinical oncology 2002;25(1):65-70.
2002: Mavroudis D; Kouroussis Ch; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Samonis G; Georgoulias V
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Oncology 2002;62(3):216-22.
2001: Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Kalbakis K; Rapti A; Androulakis N; Georgoulias V; Papadakis E
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S77-80.
2001: Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
European journal of cancer (Oxford, England : 1990) 2001;37(15):1833-8.
2001: Kouroussis C; Kakolyris S; Mavroudis D; Androulakis N; Kalbakis K; Agelaki S; Sarra E; Souglakos J; Christodoulakis M; Samonis G; Georgoulias V
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):404-7.
2001: Kakolyris S; Papadakis E; Tsiafaki X; Kalofonos C; Rapti A; Toubis M; Bania E; Kouroussis C; Chainis K; Androulakis N; Agelaki S; Sarra E; Vardakis N; Georgoulias V;
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):179-87.
2001: Kakolyris S; Mavroudis D; Tsavaris N; Souglakos J; Tsiafaki P; Kalbakis K; Agelaki S; Androulakis N; Georgoulias V
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):193-7.
2001: Kakolyris S; Kouroussis C; Souglakos J; Mavroudis D; Agelaki S; Kalbakis K; Androulakis N; Vardakis N; Vamvakas L; Georgoulias V
A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.
Oncology 2001;61(4):265-70.
2001: Kouroussis C; Souglakos J; Kakolyris S; Mavroudis D; Malamos N; Kalbakis K; Androulakis N; Agelaki A; Vardakis N; Samonis G; Georgoulias V
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Oncology 2001;61(1):36-41.
2001: Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Harpidou A; Kalbakis K; Rapti A; Androulakis N; Sarra E; Georgoulias V; Papadakis E
Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
Oncology 2001;60(3):235-41.
2001: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Mavroudis D; Kalbakis K; Kotsakis A; Vardakis N; Koukourakis M; Romanos J; Georgoulias V
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
Oncology 2001;60(3):207-13.
2000: Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
2000: Kouroussis C; Samonis G; Androulakis N; Souglakos J; Voloudaki A; Dimopoulos M A; Kotsakis T; Kakolyris S; Kalbakis K; Georgoulias V
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.
American journal of clinical oncology 2000;23(3):309-13.
2000: Giannakakis T; Ziras N; Kakolyris S; Mavroudis D; Androulakis N; Agelaki S; Parashos M; Sarra E; Dimou T; Hatzidaki D; Vlachonikolis J; Georgoulias V
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
2000: Mavroudis D; Kourousis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Samonis G; Georgoulias V
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.
Seminars in oncology 2000;27(1 Suppl 2):25-30.
1999: Kakolyris S; Kourousis C; Koukourakis M; Androulakis N; Vamvakas L; Agelaki S; Hatzidaki D; Samonis G; Tsiftsis D; Georgoulias V
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Androulakis N; Kourousis C; Dimopoulos M A; Samelis G; Kakolyris S; Tsavaris N; Genatas K; Aravantinos G; Papadimitriou C; Karabekios S; Stathopoulos G P; Georgoulias V
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Georgoulias V; Kouroussis C; Androulakis N; Kakolyris S; Dimopoulos M A; Papadakis E; Bouros D; Apostolopoulou F; Papadimitriou C; Agelidou A; Hatzakis K; Kalbakis K; Kotsakis A; Vardakis N; Vlachonicolis J
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):914-20.
1999: Kouroussis C; Androulakis N; Kakolyris S; Souglakos J; Kotsakis T; Mavroudis D; Katsogridakis K; Vardakis N; Hatzidaki D; Samonis G; Vlachonikolis J; Georgoulias V
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):862-9.
1999: Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Cancer chemotherapy and pharmacology 1999;43(3):257-62.
1998: Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
Cancer 1998;83(10):2083-90.
1998: Androulakis N; Kouroussis C; Kakolyris S; Tzannes S; Papadakis E; Papadimitriou C; Geroyianni A; Georgopoulou T; Dimopoulou I; Souglakos J; Kotsakis A; Vardakis N; Hatzidaki D; Georgoulias V
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1127-30.
1998: Georgoulias V; Androulakis N; Bouros D; Kouroussis C; Chatzakis K; Papadakis M; Apostopoloulou F; Georgopoulou T; Kotsakis T; Souklakos J; Hatzidaki D; Vlachonikolis J; Panagos G
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
Lung cancer (Amsterdam, Netherlands) 1998;21(3):213-20.
1998: Kourousis C; Kakolyris S; Androulakis N; Heras P; Vlachonicolis J; Vamvakas L; Vlata M; Hatzidaki D; Samonis G; Georgoulias V
Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer.
American journal of clinical oncology 1998;21(3):226-32.
1998: Koukourakis M I; Kourousis C; Kamilaki M; Koukouraki S; Giatromanolaki A; Kakolyris S; Kotsakis A; Androulakis N; Bahlitzanakis N; Georgoulias V
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.
European journal of cancer (Oxford, England : 1990) 1998;34(6):838-44.
1998: Georgoulias V; Androulakis N; Dimopoulos A M; Kourousis C; Kakolyris S; Papadakis E; Apostolopoulou F; Papadimitriou C; Vossos A; Agelidou M; Heras P; Tzannes S; Vlachonicolis J; Mavromanolakis E; Hatzidaki D
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):331-4.
1997: Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Dimopoulos M A; Bouros D; Papadimitriou C; Hatzakis K; Heras P; Kalbakis K; Kotsakis T; Vardakis N; Meramveliotakis N; Hatzidaki D
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Seminars in oncology 1997;24(4 Suppl 14):S14-22-S14-25.
1997: Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-9-S14-14.
1997: Georgoulias V; Kourousis C; Kakolyris S; Androulakis N; Dimopoulos M A; Papadakis E; Kotsakis T; Vardakis N; Kalbakis K; Merambeliotakis N; Hatzidaki D
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.
Seminars in oncology 1997;24(4 Suppl 12):S12-61-S12-66.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nikolaos Androulakis

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nikolaos Androulakis (preview)

All Publications